Galena Biopharma to Present at the 8th Annual JMP Securities Healthcare Conference

LAKE OSWEGO, Ore., July 2, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President & CEO, will present a corporate update at the 8th Annual JMP Securities Healthcare Conference. The presentation will take place on Wednesday, July 10, 2013 at 10:30 a.m. ET at The St. Regis Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

CONTACT: Remy Bernarda Senior Director, Communications (503) 405-8258 rbernarda@galenabiopharma.com

Source:Galena Biopharma